Deregulated axis involving the overproduction of interleukin 23 (IL-23), and the consequent activation of IL-17-producing T cell subsets (T17), recently emerged as the central immune pathway driving the development of psoriasis (5, 6). Here, IL17A is linked to psoriasis.